Home / Whitepapers
Biosimilars Council advocates for policies that support patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/73dlNwCdqQ…
Yesterday was National #RheumatoidArthritis Awareness Day! RA brings pain to more than 1.5 million Americans, but relief is on the horizon as #biosimilar versions of #Humira become available.
Check out our blog from last year: https://bit.ly/3JjHLmG
BOOK NOW! This year, #Access2023, the @AccessibleMeds annual meeting, will feature special guest @mcuban!
Immediately following Access!, IGBA will host its annual meeting in the SAME LOCATION!
Sign up today: https://access.accessiblemeds.org
Another clear example of how #PBM rebate schemes keep #drugprices high for patients: "When 5% off is a better deal than 55% off."
Read more in @statnews:
#biosimilars #Humira #adalimumab
601 New Jersey Ave NW, Suite 850 Washington DC 20001
202.249.7100 | [email protected]
©2022. Biosimilars Council, All Rights Reserved.